LMR Partners LLP Sells 7,089 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

LMR Partners LLP trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 66.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,526 shares of the medical equipment provider’s stock after selling 7,089 shares during the quarter. LMR Partners LLP’s holdings in Intuitive Surgical were worth $1,840,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $82,517,000. Sycomore Asset Management grew its stake in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. China Universal Asset Management Co. Ltd. grew its stake in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. Finally, Brookstone Capital Management grew its stake in shares of Intuitive Surgical by 25.4% in the fourth quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider’s stock worth $9,448,000 after purchasing an additional 3,663 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.4%

Shares of NASDAQ ISRG opened at $563.95 on Wednesday. The firm’s 50-day moving average price is $501.31 and its 200-day moving average price is $535.58. Intuitive Surgical, Inc. has a 1-year low of $379.67 and a 1-year high of $616.00. The firm has a market capitalization of $202.13 billion, a P/E ratio of 87.98, a P/E/G ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the business earned $1.50 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ISRG. Royal Bank of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Citigroup boosted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Barclays reduced their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, Piper Sandler dropped their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $598.95.

Insider Transactions at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares of the company’s stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 2,401 shares of the business’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $205,093. The trade was a 87.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,636 shares of company stock valued at $16,829,815 over the last three months. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.